Nov 3 (Reuters) - biOasis Technologies Inc BTI.V :
* BIOASIS ANNOUNCES SALE OF ROYALTY INTEREST IN LYSOSOMAL STORAGE DISORDER ENZYMES BEING DEVELOPED UNDER THE CHIESI GROUP–BIOASIS STRATEGIC ALLIANCE TO XOMA CORPORATION
* BIOASIS - IN EXCHANGE FOR $1.2 MILLION UPFRONT PAYMENT, XOMA TO RECEIVE LOW SINGLE-DIGIT ROYALTY ON FUTURE SALES OF EACH OF 4 CHIESI GROUP-BIOASIS ENZYMES